Industry

BEIJING–(BUSINESS WIRE)–Latest data of InnoCare’s robust oncology pipeline were presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Poster Presentation 1: Phase I results of gunagratinib (ICP-192), a highly selective irreversible FGFR 1-4 inhibitor in patients with head and neck cancer (HNC) harboring FGF/FGFR gene aberrations Abstract Number: 6039 In the dose-escalation … [Read more…]

Average monthly enrollment nearly doubled with pharmacy intervention Remote pharmacist easily adapted into clinic workflows in community practices THE WOODLANDS, Texas–(BUSINESS WIRE)–Results from the second phase of the broad, collaborative MYLUNG ConsortiumTM research study in non-small cell lung cancer (NSCLC) were presented by The US Oncology Network (The Network), US Oncology Research and Ontada® at … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Korro Bio, Inc., a leading RNA editing company focused on the discovery and development of novel genetic medicines, today announced that Ram Aiyar, Ph.D., MBA, Chief Executive Officer, will present at the 2022 Jefferies Healthcare Conference, being held in New York, NY, on Thursday, June 9, 2022, at 10:30 a.m. EDT. About Korro … [Read more…]

NEW ORLEANS–(BUSINESS WIRE)–$TNDM #TNDM–Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced positive real-world data demonstrating immediate and sustained benefits in a diverse cohort of people using the t:slim X2™ insulin pump with Control-IQ® technology. The data was presented at the American Diabetes Association (ADA) 82nd Scientific Sessions in New … [Read more…]

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conference in June: Goldman Sachs 43rd Annual Global Health Care Conference Date: Tuesday, June 14, 2022 Presentation Time: 11 a.m. ET The conference presentation will be webcast live and may be accessed by visiting Horizon’s website at http://ir.horizontherapeutics.com. A … [Read more…]

LITTLE ELM, Texas–(BUSINESS WIRE)–Retractable Technologies, Inc. (NYSE American: RVP) reports that it has reduced its workforce by approximately 16% as a result of the substantial completion of its facility expansion efforts and the completion of U.S. government orders to provide its products for COVID-19 vaccination efforts. The staff reduction primarily affects its production, operations and … [Read more…]

CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced abstracts accepted for presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, which convenes in Chicago from June 3-7, 2022. Tempus is presenting fourteen abstracts, including one oral presentation, two poster discussions, and eleven poster presentations. “The research we’re presenting … [Read more…]

With products now available in South Korea, partnership broadens access to single cell genomics research in Asia SEATTLE–(BUSINESS WIRE)–Parse Biosciences, a leading provider of scalable single-cell sequencing solutions, today announced a partnership with Molecular Diagnostics Korea (MDxK) that will expand its presence in Asia by providing its entire line of Evercode™ Whole Transcriptome products as … [Read more…]

Miami Mayor and U.S. Conference of Mayors President Francis Suarez rallies the nation’s mayors to step on healthy buildings by embracing WELL as a key solution for advancing healthier cities. RENO, Nev.–(BUSINESS WIRE)–Today, as part of a renewed commitment to public health and national resilience, the nation’s mayors passed a major resolution to advance healthy … [Read more…]

Introducing an entirely new multitasking experience with Stage Manager and full external display support, new ways to collaborate via Messages, big updates to Mail and Safari, iCloud Shared Photo Library, pro features including Reference Mode and Display Zoom, and more CUPERTINO, Calif.–(BUSINESS WIRE)–Apple® today previewed iPadOS® 16, a major update that makes the iPad® experience … [Read more…]